免疫PET向受体氨酸激酶:临床应用
Flavia Linguanti1,2, Elisabetta Maria Abenavoli3, Raffaella Calabretta4
1Nuclear Medicine Unit, Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.
Cancers
|December 23, 2023
概括
免疫PET成像显示了评估受体氨酸激酶 (RTK) 表达和指导抗癌疗法的前景. 本综述强调了针对RTK的ImmunoPET临床研究,特别是 HER家族和VEGF/R.
科学领域:
- 在瘤学瘤学.
- 分子成像学分子成像学
- 生物化学 生物化学
背景情况:
- 受体氨酸激酶 (RTK) 是关键的细胞表面受体,调节重要的细胞过程,如增殖和生存.
- RTKs的失调与各种癌症有关,使它们成为重要的治疗点.
研究的目的:
- 审查目前关于针对癌症治疗RTK的免疫PET成像的临床研究.
- 专注于针对表皮生长因子受体 (HER) 家族和血管内皮生长因子受体 (VEGF/R) 的免疫PET应用.
主要方法:
- 审查现有使用ImmunoPET进行RTK表达分析的临床研究.
- 分析单克隆抗体 (mAbs) 和抗体碎片作为免疫PET中的向剂.
主要成果:
- 免疫PET是评估RTK表达和癌症治疗疗效的有希望的工具.
- 针对HER家族和VEGF/R的ImmunoPET的临床数据显示了个性化医疗的潜力.
结论:
- 免疫PET提供了一种非侵入性方法来评估瘤中的RTK状态.
- 用ImmunoPET准RTK可以帮助开发新的抗癌疗法和监测治疗反应.
关键词:
欧洲农业基金会 (EGFR) 是一个.在HER2中,HER2是HER2.在HER3中,HER3是HER3.免疫性PET是一种PET.聚乙烯/聚乙烯/聚乙烯RTK RTK RTK 这是一个很好的方法.在VEGF中,VEGF是VEGF.接收器氨酸激酶的受体更多相关视频
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.4K
11:34Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT
Published on: April 29, 2017
8.9K
相关概念视频
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K